Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare ...
Omeros Corporation maintained with Strong Buy rating after securing a $2.1 billion partnership with Novo Nordisk for ...
Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.
From an early age, Dr. Kelli Crabtree-Wilson was fascinated by the human nervous system. Personal experiences sparked her ...
The denim supply chain officially kicked off the Spring/Summer 2027 season last week at Kingpins Amsterdam.
Significant proteinuria reduction maintained at one year, regardless of immunosuppressant use or baseline proteinuria levels Complete proteinuria ...
Gamification is now a $19 billion industry, which still has lots of growth potential. One organization that is using it for ...
Alert systems, also known as trigger-based systems, provide a critical advantage over raw data delivery approaches by ...
Phytochelatin synthases (PCSs) produce phytochelatins—tiny, cysteine-rich peptides that bind and neutralize toxic metal ions ...
My honest FOLD Reformer review after four months of testing at home — covering setup, performance and whether it’s worth the ...
Department of Orthopedic Surgery, University of California, San Francisco, San Francisco, United States ...
AllAfrica on MSN
Global Forest Loss - Far Off Track From Global Commitments
Closing legal loopholes that allow deforestation-linked products to enter markets and getting international lenders to align funding with environmental goals are key to ending deforestation, says Erin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback